Gastric cancer chemoprevention: the current evidence - PubMed (original) (raw)

Review

. 2013 Jun;42(2):299-316.

doi: 10.1016/j.gtc.2013.02.001. Epub 2013 Mar 13.

Affiliations

Review

Gastric cancer chemoprevention: the current evidence

Victoria P Y Tan et al. Gastroenterol Clin North Am. 2013 Jun.

Abstract

Chemoprevention may form the cornerstone in the management of gastric adenocarcinoma of the future. Helicobacter pylori eradication and aspirin and/or nonsteroidal anti-inflammatory drug therapy have emerged as front-runner chemotherapeutic agents due to the putative pathogenic mechanisms that they address. Before a population-based chemopreventive strategy can be recommended on a large scale, randomized controlled trials with follow-up of more than 10 years of these 2 agents in populations at high gastric adenocarcinoma risk is urgently awaited.

Copyright © 2013 Elsevier Inc. All rights reserved.

PubMed Disclaimer

Similar articles

Cited by

Publication types

MeSH terms

Substances

LinkOut - more resources